As of 2026-04-19, the Relative Valuation of Ocular Therapeutix Inc (OCUL) is (22.84) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.82 USD, the upside of Ocular Therapeutix Inc based on Relative Valuation is -332.6%.
The range of the Relative Valuation is (21.72) - (23.19) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 20.0x | 19.3x |
| Forward P/E multiples | 15.9x - 19.0x | 18.1x |
| Fair Price | (21.72) - (23.19) | (22.84) |
| Upside | -321.2% - -336.1% | -332.6% |
| Date | P/E |
| 2026-04-17 | -7.90 |
| 2026-04-16 | -7.25 |
| 2026-04-15 | -7.29 |
| 2026-04-14 | -7.17 |
| 2026-04-13 | -7.25 |
| 2026-04-10 | -7.20 |
| 2026-04-09 | -7.61 |
| 2026-04-08 | -6.89 |
| 2026-04-07 | -6.83 |
| 2026-04-06 | -6.61 |
| 2026-04-02 | -6.95 |
| 2026-04-01 | -6.82 |
| 2026-03-31 | -6.93 |
| 2026-03-30 | -6.06 |
| 2026-03-27 | -6.18 |
| 2026-03-26 | -6.61 |
| 2026-03-25 | -6.82 |
| 2026-03-24 | -6.63 |
| 2026-03-23 | -6.63 |
| 2026-03-20 | -6.70 |
| 2026-03-19 | -6.77 |
| 2026-03-18 | -6.95 |
| 2026-03-17 | -7.11 |
| 2026-03-16 | -7.06 |
| 2026-03-13 | -7.17 |
| 2026-03-12 | -7.26 |
| 2026-03-11 | -7.78 |
| 2026-03-10 | -8.08 |
| 2026-03-09 | -8.14 |
| 2026-03-06 | -8.41 |
| 2026-03-05 | -8.46 |
| 2026-03-04 | -9.04 |
| 2026-03-03 | -8.81 |
| 2026-03-02 | -8.99 |
| 2026-02-27 | -7.32 |
| 2026-02-26 | -7.85 |
| 2026-02-25 | -7.78 |
| 2026-02-24 | -7.33 |
| 2026-02-23 | -6.88 |
| 2026-02-20 | -6.37 |
| 2026-02-19 | -5.75 |
| 2026-02-18 | -5.63 |
| 2026-02-17 | -5.72 |
| 2026-02-13 | -7.27 |
| 2026-02-12 | -7.42 |
| 2026-02-11 | -7.50 |
| 2026-02-10 | -7.39 |
| 2026-02-09 | -7.72 |
| 2026-02-06 | -7.50 |
| 2026-02-05 | -7.29 |